Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Benoxinate Hydrochloride bulk supplier for pharma manufacturers

Benoxinate Hydrochloride 0.4% w/v Suppliers & Bulk Manufacturers

Available Forms: Ophthalmic Solution

Available Strengths: 0.4% w/v

Reference Brands: Generic formulations marketed under different names

Category: Anaesthetics

Benoxinate Hydrochloride is a Anaesthetics product available as Ophthalmic Solution in strengths 0.4% w/v. It corresponds to the reference brand Generic formulations marketed under different names. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Benoxinate Hydrochloride is a fast-acting topical local anesthetic primarily used in ophthalmology for temporary surface anesthesia of the eye. It works by blocking nerve impulse conduction at the corneal and conjunctival surface, providing rapid numbness within seconds of application. Due to its quick onset and short duration of action, it is especially suitable for diagnostic and minor therapeutic ophthalmic procedures where brief anesthesia is required.

This medication is commonly used prior to procedures such as tonometry, gonioscopy, removal of superficial foreign bodies, corneal scraping, and minor surgical or diagnostic interventions. Benoxinate Hydrochloride allows these procedures to be performed comfortably while minimizing patient discomfort and reflex blinking. It is typically administered as an ophthalmic solution and is intended strictly for professional clinical use.

Internationally, Benoxinate Hydrochloride is also known as oxybuprocaine hydrochloride and is widely recognized in European and UK markets under established ophthalmic anesthetic brands. Compared to some other topical ocular anesthetics, it is known for causing less stinging upon instillation, which improves patient tolerance. The drug is not intended for long-term or repeated use, as prolonged exposure may cause corneal irritation or damage. When used appropriately under medical supervision, Benoxinate Hydrochloride remains a reliable and essential agent in routine ophthalmic practice.

Benoxinate Hydrochloride — third party manufacturing & bulk supply

Benoxinate Hydrochloride 0.4% w/v is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Benoxinate Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Benoxinate Hydrochloride →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions


Benoxinate hydrochloride is used as a topical local anesthetic in ophthalmology to temporarily numb the surface of the eye before diagnostic procedures such as tonometry, gonioscopy, removal of superficial foreign bodies, and minor ophthalmic interventions.


Benoxinate hydrochloride is a synthetic ester-type local anesthetic compound formulated for topical ophthalmic use.


The commonly known trade name of benoxinate hydrochloride in the EU and UK markets is Novesine, where it is also referred to as oxybuprocaine hydrochloride.


Benoxinate hydrochloride and its equivalent oxybuprocaine hydrochloride formulations are manufactured by multiple pharmaceutical companies globally, depending on the brand and market.


The generic name is benoxinate hydrochloride, which is internationally also known as oxybuprocaine hydrochloride.


The brand name commonly associated with this product is Novesine in the EU and UK, while it is mainly available as a generic formulation in the USA.


Benoxinate hydrochloride ophthalmic formulations are manufactured in various countries including the EU, UK, USA, and India, depending on the pharmaceutical manufacturer and regulatory approvals.

Related Products

Sufentanil Citrate

Strength:
50 mcg/mL, 100 mcg/mL, 15 mcg

Form: Tablet / Injection

Reference Brands: Sufenta (USA/EU), Dsuvia (USA/EU)

View Details
Pancuronium Bromide

Strength:
1 mg/mL, 2 mg/mL

Form: Injection

Reference Brands: Pavulon (USA/EU)

View Details
Dyclonine Hydrochloride

Strength:
0.5% w/v, 1% w/v

Form: topical solution/ lozenges / sprays

Reference Brands: Sucrets Complete (USA)

View Details
Droperidol

Strength:
2.5 mg/mL , 5 mg/mL

Form: Injection

Reference Brands: Droleptan (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.